A private room can be inspected. A beautiful setting can be photographed. Recovery requires a different kind of evidence. For families choosing private mental health treatment, the difficult question is not how many services a program includes. It is what happens to the people who enter it, and whether the published results provide an honest answer.
Key findings
670,419: completed courses recorded by England’s NHS Talking Therapies program in 2024/25.
8.4: average treatment sessions in that report.
50.5%: the program-defined recovery rate in 2024/25, compared with 50.1% in 2023/24.
0.4 percentage points: the difference between those annual recovery rates.
These published program figures illustrate transparent measurement. They are not a direct benchmark for residential clinics or evidence that price determines recovery. [1]
A recovery percentage needs a definition
Source: NHS England, 2024/25 annual report. Recovery is measured at treatment completion, not six or twelve months after discharge. [1]
NHS Talking Therapies uses condition-appropriate questionnaires and clinical thresholds. Broadly, an eligible referral counts as recovered when symptoms meet the program’s clinical threshold at the start but no longer meet it at the end. Reliable improvement and reliable recovery are separate measures. The definitions determine what each result can tell us. [2]
Someone can improve substantially without crossing a threshold. Someone else can cross it while still struggling with sleep, relationships, or work. Neither result makes measurement pointless. It shows why one score should not carry the entire account of recovery.
Price describes the purchase, not the result
Privacy, timely access, experienced clinicians, and a suitable environment are legitimate considerations. They describe how care is delivered. They do not, on their own, demonstrate that it improved a person’s health. A list of therapies is not proof that every component adds benefit. A testimonial is not a follow-up study.
For an affluent family, purchasing power may make many options available. The decision still requires an assessment of clinical need. Higher fees do not automatically mean more appropriate care, and lower fees do not establish poorer quality. Comparing photographs and weekly prices cannot answer a clinical question.
A fair comparison starts with the patients, the treatment, and the result being measured. It also separates evidence supporting individual therapies from evidence evaluating the complete program. A clinic should not present a general psychotherapy study as a measurement of its own success rate.
| Claim | Evidence to inspect | What remains unanswered |
|---|---|---|
| Fast access | Time to assessment and treatment | Did health improve? |
| High satisfaction | Questions, response rate, and timing | Was treatment effective? |
| Symptom improvement | Measure, starting severity, and change | Did daily functioning improve? |
| Sustained recovery | Follow-up, recurrence, and missing results | What contributed to the result? |
| Better than another clinic | Comparable patients and methods | Does the difference reflect treatment? |
The same result can produce three percentages
Consider a hypothetical program with 100 admissions. Eighty people complete treatment, 60 answer a follow-up survey, and 48 respondents report the specified improvement. Those 48 people represent 80% of respondents, 60% of completers, or 48% of admissions. Each percentage answers a different question.
THE BALANCE arithmetic illustration. These are not results from THE BALANCE or any other provider.
The 40 people without follow-up should not automatically count as failures. They should not be assumed to have recovered either. Their outcomes are unknown. An honest report states the observed result and the missing information, then examines how different assumptions might change the interpretation.
That is why a headline success rate needs a denominator. Families should ask who was eligible, who participated, who left early, and who was reached later. A high percentage among a small group of respondents can be less informative than a more modest result with complete follow-up.
Recovery should survive the return home
A discharge assessment describes a particular moment. Follow-up asks whether improvement lasted in the person’s usual environment. For someone returning to leadership, a family business, or frequent travel, relevant outcomes may include sustainable functioning and the ability to continue care.
Those goals should not be reduced to revenue or hours worked. WHO connects participation in work with continuing clinical support, rather than treating economic output as a definition of recovery. A person may improve while choosing a different workload or role. [3]
Later assessments should record symptoms, functioning, and the person’s priorities. They should also record subsequent treatment. Otherwise, a provider may receive credit for improvement partly supported by another clinician or a later intervention.
What families should ask before admission
Ask for the latest outcome report and its reporting period. Look for admission numbers, completion numbers, diagnoses, starting severity, measures, and follow-up response rates. Ask whether the report includes early departures, deterioration, and adverse events.
Then ask whether the studied patients resemble the person considering care. Results from a narrowly selected outpatient group may not apply to someone with several co-occurring conditions or a different level of need. A more complex patient group should not be penalized for having a harder starting point.
Finally, clarify what the fee covers. Assessment, medication, travel, continuing care, and treatment length may differ between packages. The comparison should make those differences visible without suggesting that slower improvement makes a person less deserving of treatment.
Make the evidence useful for the person deciding
The first conversation should connect the outcome report to the proposed treatment. Which difficulties are expected to improve, and what would a worthwhile change look like for this person? The answer may involve symptoms, relationships, physical health, or the ability to maintain ordinary routines. A provider’s preferred marketing measure may not capture the patient’s main concern.
Follow-up arrangements deserve the same scrutiny as the residential stay. Ask when assessments occur, who conducts them, and whether later care is included in the fee. Clarify what happens when someone returns to another country. These questions concern the completeness of the proposed pathway. They do not assume that international travel itself causes poor outcomes.
A transparent report should distinguish measured change from explanation. Improvement after admission is an observation. Claiming that a particular program caused the improvement requires a stronger design. Concurrent medication, later therapy, changes at home, and the natural course of symptoms may all need consideration. Naming those possibilities is more informative than claiming that every observed improvement belongs to the provider.
Comparisons should also make room for patient choice. Some people prioritize a setting that protects privacy or allows a family member to participate appropriately. Those preferences can legitimately influence a decision without being converted into claims of superior clinical effectiveness. The useful distinction is between a reason to choose a service and evidence that its treatment works better.
For journalists, a disclosure audit could turn these questions into a concrete investigation. It would select providers using stated criteria, record what was publicly available on a specified date, and ask each provider to clarify apparent gaps. Missing public information would be reported as a disclosure gap, not automatically as evidence of poor clinical care. No such provider audit is presented here.
The immediate test is simpler: can a reader understand the result without asking the clinic to explain which patients were omitted? A useful report gives the numerator, denominator, timing, and definition together. It should not require the family to reconstruct those details from separate pages or rely on a favorable testimonial to fill the gaps.
What these numbers cannot tell us
This analysis does not estimate the relationship between treatment price and recovery. It contains no matched public-private dataset, named-provider audit, or THE BALANCE patient results. The NHS figures demonstrate reporting principles, not a residential-treatment benchmark.
A credible provider comparison would define the patient group, outcomes, and follow-up in advance. It would account for starting severity, prior treatment, and missing data. STROBE provides reporting guidance for observational research, but a checklist cannot turn an uncontrolled study into proof that treatment caused the result. [4]
The bottom line
Luxury can describe an environment. It cannot substitute for a definition of recovery. The strongest answer a provider can offer is a clear account of whom it treats, how it measures progress, and what it knows about life after discharge. That standard should apply to THE BALANCE as well.
For journalists
Key comparison: NHS Talking Therapies reported recovery of 50.1% in 2023/24 and 50.5% in 2024/25 among eligible completed referrals.
Important distinction: the 80%, 60%, and 48% example is hypothetical. It explains denominator choice and is not clinical outcome data.
Suggested attribution: THE BALANCE analysis of published outcome reporting and measurement principles.
Methodology and sources
This narrative analysis retains the original report’s fiscal-year comparisons. It combines published program statistics with measurement guidance. The denominator example is calculated separately. No price-effect estimate, patient survey, or original clinical study was conducted.
